Haleon Completes Deal To Grow Stake In China JV

 
• By Tom Gallen

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.

Business_China
The deal offers access to China for Alvotech’s biosimilars portfolio • Source: Shutterstock

More from Deals

More from Geography